2011
DOI: 10.1128/jvi.00393-11
|View full text |Cite
|
Sign up to set email alerts
|

Cyclophilin A Interacts with Domain II of Hepatitis C Virus NS5A and Stimulates RNA Binding in an Isomerase-Dependent Manner

Abstract: NS5A plays a critical, yet poorly defined, role in hepatitis C virus genome replication. The protein consists of three domains, each of which is able to bind independently to the 3 untranslated region (UTR) of the viral positive strand genomic RNA. The peptidyl-prolyl isomerase cyclophilin A (CypA) binds to domain II, catalyzing cis-trans isomerization. CypA inhibitors such as cyclosporine (CsA) have been shown to inhibit hepatitis C virus (HCV) replication. We show here that CypA stimulated domain II RNA bind… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
104
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 111 publications
(113 citation statements)
references
References 19 publications
7
104
2
Order By: Relevance
“…Therefore, NS5A may be considered as a therapeutic vaccine candidate for chronic HCV infection. Moreover, even though NS5A may interfere with cellular signaling pathways including molecules and cells involved in innate and adaptive immunity (20,34,35), long-term intrahepatic NS5A protein expression does not induce any liver disease (20,36).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, NS5A may be considered as a therapeutic vaccine candidate for chronic HCV infection. Moreover, even though NS5A may interfere with cellular signaling pathways including molecules and cells involved in innate and adaptive immunity (20,34,35), long-term intrahepatic NS5A protein expression does not induce any liver disease (20,36).…”
Section: Discussionmentioning
confidence: 99%
“…Domain III is required for proper assembly of viral particles (31) but is not needed for RNA replication (32). NS5A has been described to interact both with cellular proteins like Raf-1, p53, PI3K, and Grb2, which are important for host cell signaling (20,33), but also to interfere with components of innate immunity by inhibiting PKR and cyclophilin A (33)(34)(35). Hence, NS5A may affect IFN signaling pathways and production of proinflammatory cytokines.…”
Section: Hronic Liver Disease Caused By the Hepatitis C Virus (Hcv)mentioning
confidence: 99%
“…Unfortunately, a connection between the NS5A RNA binding activity and a specific aspect of RNA replication or virion assembly remains to be established (30). A recent study showed that both Domains I and II of NS5A exhibit RNA binding activities (20). However, the ability to bind specifically to uridine-and guanosine-rich RNA resides in domain I and the adjacent linker region (33).…”
Section: Hepatitis C Virus (Hcv)mentioning
confidence: 99%
“…As a control, we used GSTCypA as bait to capture full-length NS5A-His because this interaction has been shown to be direct (15)(16)(17)(18)(19)(20)(21)(22). As expected, both GST-CypA and GST-Domain I, but not GST, capture fulllength NS5A-His (Fig.…”
Section: Ns5a Forms Dimers Directly Through Domain I Interactions-mentioning
confidence: 99%
See 1 more Smart Citation